Renal Cancer - Results from #3880

Soluble Ligand of the Immune Checkpoint Receptor (sPD-L1) in Blood Serum of Patients with Renal Cell Carcinoma. January 14, 2019

Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders. January 11, 2019

Radiomics in Kidney Cancer: MR Imaging. January 11, 2019

Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile. January 11, 2019

A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC). January 10, 2019

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study. January 10, 2019

External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model. January 10, 2019

Suppression of Tescalcin inhibits growth and metastasis in renal cell carcinoma via downregulating NHE1 and NF-kB signaling. January 9, 2019

Classification of positive surgical margins and tumor recurrence after nephron-sparing surgery for small renal masses. January 9, 2019

National trends and economic impact of surgical treatment for benign kidney tumors. January 9, 2019

A large Number of Metastatic Subcutaneous Nodules: A Complication of Percutaneous Biopsy for Atypical Renal Cell Carcinoma. January 8, 2019

Ki-67 index and percentage of sarcomatoid differentiation were two independent prognostic predictors in sarcomatoid renal cell carcinoma. January 8, 2019

The role of vascular clamping during robot-assisted partial nephrectomy for localised renal cancer: rationale and design of the CLOCK randomised phase III study. January 8, 2019

Phase 2 Multicenter Single-Arm Study of Second-Line Axitinib in Favorable Risk Patients with Metastatic Renal Cell Carcinoma: FavorAx. January 7, 2019

Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma. January 7, 2019

Position of cytoreductive nephrectomy in the setting of metastatic renal cell carcinoma patients: does the CARMENA trial lead to a paradigm shift? January 7, 2019

HepaCAM regulates Warburg effect of renal cell carcinoma via HIF-1α/ NF-κB signaling pathway. January 4, 2019

Exploratory Investigation of Target Pazopanib Concentration Range for Patients With Renal Cell Carcinoma. January 4, 2019

RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis. January 4, 2019

Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population. January 3, 2019

Page 195 of 457